Company MedMira Inc.

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 19:00:45 30/04/2024 BST			5-day change	1st Jan Change
0.08 ^CAD	0.00%		+6.67%	-27.27%

04-02	MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
03-27	Samsung Pay to stop working with Russia's Mir payment system from April 3	RE

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

Number of employees: 52

CAD in Million	2022	Weight	2023	Weight	Delta
Rapid Diagnostic Products 59.2 %	0	37.7 %	0	59.2 %	-28.71%
Rapid Diagnostic Services 40.8 %	1	62.3 %	0	40.8 %	-70.25%

CAD in Million	2022	Weight	Weight	Delta
North America 87.8 %	1	94.5 %	87.8 %	-57.79%
Europe 7.1 %	0	3.8 %	7.1 %	-15.77%
Canada 5.1 %	0	1.7 %	5.1 %	+39.99%

Managers	Title	Age	Since
Hermes Chan FOU	Founder	-	31/12/92
Markus Meile DFI	Director of Finance/CFO	-	27/01/10
Steve Cummings BRD	Director/Board Member	60	30/04/07

Members of the board	Title	Age	Since
Hermes Chan FOU	Founder	-	31/12/92
Steve Cummings BRD	Director/Board Member	60	30/04/07
Markus Meile DFI	Director of Finance/CFO	-	27/01/10
Pascale Nini BRD	Director/Board Member	-	13/07/22
Thomas Bergmann CHM	Chairman	-	16/12/21
Jianhe Mao BRD	Director/Board Member	-	30/05/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	701,730,591	208,046,023 ( 29.65 %)	0	29.44 %
Stock B	0	5,000,000	0	0

Name	Equities	%	Valuation
MedMira Holding AG 70.14 %	489,199,013	70.14 %	40 M $
Hermes Chan 0.5897 %	4,112,500	0.5897 %	337 225 $

Name	Equities	%	Valuation
MedMira Holding AG 100.00 %	5,000,000	100.00 %	410 000 $
Hermes Chan 20.00 %	1,000,000	20.00 %	82 000 $

MedMira, Inc.

155 Chain Lake Drive Suite 1

B3S 1B3, Halifax

+902 450 1588

http://www.medmira.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDMIRA INC.	-27.27%	41.13M
THERMO FISHER SCIENTIFIC	+7.92%	220B
DANAHER CORPORATION	+6.60%	183B
INTUITIVE SURGICAL, INC.	+10.63%	133B
BOSTON SCIENTIFIC CORPORATION	+24.41%	107B
SIEMENS HEALTHINEERS AG	-0.95%	63.05B
EDWARDS LIFESCIENCES CORPORATION	+11.37%	51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.47B
AGILENT TECHNOLOGIES, INC.	-0.86%	40.91B
RESMED, INC.	+24.26%	31.91B

Other Advanced Medical Equipment & Technology